Výsledky vyhľadávania - "Cholangiocarcinoma/drug therapy"

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial

Autori: Gros, L. Bouattour, M. Dumont, C. a ďalší

Zdroj: Liver international, vol. 45, no. 8, pp. e70196

Predmety: Humans, Sunitinib/therapeutic use, Sunitinib/adverse effects, Sunitinib/blood, Male, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/mortality, Cholangiocarcinoma/pathology, Female, Middle Aged, Aged, Bile Duct Neoplasms/drug therapy, Bile Duct Neoplasms/mortality, Bile Duct Neoplasms/pathology, France, Angiogenesis Inhibitors/therapeutic use, Angiogenesis Inhibitors/adverse effects, Progression-Free Survival, Adult, Vascular Endothelial Growth Factor A/blood, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Antineoplastic Agents/adverse effects, Choi criteria, VEGF, angiogenesis inhibitors, biliary tract cancer, tumour density

Popis súboru: application/pdf

Prístupová URL adresa: https://serval.unil.ch/resource/serval:BIB_F135E275450F.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F135E275450F
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F135E275450F5

Efficacy of 2 different fibroblast growth factor receptor-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation: a case report

Autori: Ilianna Galli-Vareia Petr Szturz Ioannis A Voutsadakis a ďalší

Zdroj: Oncologist
The oncologist, vol. 30, no. 5

Predmety: Cholangiocarcinoma, Bile Duct Neoplasms, Mutation, Humans, Precision Medicine Clinic: Molecular Tumor Board, Bile Duct Neoplasms/drug therapy, Bile Duct Neoplasms/genetics, Bile Duct Neoplasms/pathology, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/genetics, Cholangiocarcinoma/pathology, Protein Kinase Inhibitors/therapeutic use, Protein Kinase Inhibitors/administration & dosage, Receptor, Fibroblast Growth Factor, Type 2/genetics, Receptor, Fibroblast Growth Factor, Type 2/antagonists & inhibitors, FGFR2 mutation, cholangiocarcinoma, next-generation sequencing, targeted therapy, Receptor, Fibroblast Growth Factor, Type 2, Protein Kinase Inhibitors

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40338217
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8410EE8EF7F37
https://serval.unil.ch/notice/serval:BIB_8410EE8EF7F3
https://serval.unil.ch/resource/serval:BIB_8410EE8EF7F3.P001/REF.pdf

Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest

Autori: Mancarella, Serena Gigante, Isabella Pizzuto, Elena a ďalší

Zdroj: J Exp Clin Cancer Res
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-15 (2024)

Predmety: Cholangiocarcinoma progression, Gamma secretase inhibitor, Liver cancer, Tumor microenvironment, Tumor stroma, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cell Cycle Checkpoints, Xenograft Model Antitumor Assays, Cholangiocarcinoma, Mice, Cancer-Associated Fibroblasts, Bile Duct Neoplasms, Cell Line, Tumor [MeSH], Disease Progression [MeSH], Cancer-Associated Fibroblasts/pathology [MeSH], Humans [MeSH], Bile Duct Neoplasms/metabolism [MeSH], Cell Cycle Checkpoints/drug effects [MeSH], Cholangiocarcinoma/drug therapy [MeSH], Bile Duct Neoplasms/pathology [MeSH], Animals [MeSH], Cholangiocarcinoma/metabolism [MeSH], Cancer-Associated Fibroblasts/metabolism [MeSH], Mice [MeSH], Cholangiocarcinoma/pathology [MeSH], Xenograft Model Antitumor Assays [MeSH], Bile Duct Neoplasms/drug therapy [MeSH], Cholangiocarcinoma/genetics [MeSH], Bile Duct Neoplasms/genetics [MeSH], Cell Line, Tumor, Disease Progression, Humans, Animals, RC254-282

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39415286
https://doaj.org/article/f7201f2a93ed4fb2bd5f4cc907746a8b
https://hdl.handle.net/11562/1143928
https://doi.org/10.1186/s13046-024-03210-9
https://repository.publisso.de/resource/frl:6519211

HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma

Autori: Cigliano, Antonio Gigante, Isabella Serra, Marina a ďalší

Zdroj: J Exp Clin Cancer Res
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-17 (2024)

Predmety: Heat Shock Transcription Factors/metabolism [MeSH], Cell Line, Tumor [MeSH], Cell Proliferation [MeSH], Heat Shock Transcription Factors/genetics [MeSH], Humans [MeSH], Bile Duct Neoplasms/metabolism [MeSH], Cholangiocarcinoma/drug therapy [MeSH], Bile Duct Neoplasms/pathology [MeSH], Mouse models, Animals [MeSH], Intrahepatic cholangiocarcinoma, Cholangiocarcinoma/metabolism [MeSH], Mice [MeSH], Cholangiocarcinoma/pathology [MeSH], Research, Navitoclax, Prognosis [MeSH], Bile Duct Neoplasms/drug therapy [MeSH], HSF1, Cholangiocarcinoma/genetics [MeSH], KRIBB-11, Disease Models, Animal [MeSH], Bile Duct Neoplasms/genetics [MeSH], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Cholangiocarcinoma, Mice, Disease Models, Animal, Heat Shock Transcription Factors, Bile Duct Neoplasms, Cell Line, Tumor, Humans, Animals, RC254-282, Cell Proliferation

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39243039
https://doaj.org/article/4358a36380b8455e977ec4053d406fe2
https://repository.publisso.de/resource/frl:6508490

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)

Autori: Choong-Kun, Lee Hong Jae, Chon Jaekyung, Cheon a ďalší

Prispievatelia: Choong-Kun, Lee Hong Jae, Chon Jaekyung, Cheon a ďalší

Zdroj: The Lancet Gastroenterology & Hepatology. 8:56-65

Predmety: Fluorouracil / adverse effects, Leucovorin, Intrahepatic / pathology, Cholangiocarcinoma, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols, Cholangiocarcinoma* / drug therapy, Humans, Oxaliplatin / therapeutic use, Bile Duct Neoplasms* / drug therapy, Leucovorin / adverse effects, Trastuzumab, Gemcitabine, Oxaliplatin, Biliary Tract Neoplasms* / pathology, Biliary Tract Neoplasms, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Cisplatin / adverse effects, Quality of Life, Bile Ducts, Fluorouracil, Cisplatin, Trastuzumab / adverse effects

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36328033

Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma

Autori: Chiara Raggi Maria Letizia Taddei Elena Sacco a ďalší

Prispievatelia: Chiara Raggi Maria Letizia Taddei Elena Sacco a ďalší

Zdroj: Raggi, C, Taddei, M L, Sacco, E, Navari, N, Correnti, M, Piombanti, B, Pastore, M, Campani, C, Pranzini, E, Iorio, J, Lori, G, Lottini, T, Peano, C, Cibella, J, Lewinska, M, Andersen, J B, di Tommaso, L, Viganò, L, Di Maira, G, Madiai, S, Ramazzotti, M, Orlandi, I, Arcangeli, A, Chiarugi, P & Marra, F 2021, ' Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma ', Journal of Hepatology, vol. 74, no. 6, pp. 1373-1385 . https://doi.org/10.1016/j.jhep.2020.12.031

Predmety: Male, 0301 basic medicine, Indoles, Carcinogenesis, PGC-1α, Mice, SCID, Oxidative Phosphorylation, CCLP1, HUCCT1, OXPHOS, SR-18292, Cholangiocarcinoma, Mice, Metformin/administration & dosage, Mice, Inbred NOD, Signal Transduction/drug effects, PGC-1?, Propanols/administration & dosage, Oxidative Phosphorylation/drug effects, 0303 health sciences, Tumor, Electron Transport Complex II, Indoles/administration & dosage, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/antagonists & inhibitors, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Progression-Free Survival, Metformin, Mitochondria, 3. Good health, Treatment Outcome, Phenotype, Neoplastic Stem Cells, Epithelial-Mesenchymal Transition/drug effects, Electron Transport Complex II/metabolism, Tumor Burden/drug effects, Epithelial-Mesenchymal Transition, SCID, Transfection, Cell Line, 03 medical and health sciences, Neoplastic Stem Cells/metabolism, Cell Line, Tumor, Mitochondria/metabolism, Cholangiocarcinoma/drug therapy, Animals, Humans, Gene Silencing, Bile Duct Neoplasms/drug therapy, Carcinogenesis/drug effects, Xenograft Model Antitumor Assays, Bile Duct Neoplasms, Inbred NOD

Popis súboru: application/pdf; STAMPA

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/33484774
https://www.ncbi.nlm.nih.gov/pubmed/33484774
https://boa.unimib.it/handle/10281/314811
https://pubmed.ncbi.nlm.nih.gov/33484774/
https://air.unimi.it/handle/2434/825203
https://www.sciencedirect.com/science/article/pii/S0168827821000246
https://europepmc.org/article/MED/33484774
https://hdl.handle.net/20.500.14243/450171
http://www.scopus.com/record/display.url?eid=2-s2.0-85104152123&origin=inward
https://doi.org/10.1016/j.jhep.2020.12.031
https://hdl.handle.net/2434/825203
https://doi.org/10.1016/j.jhep.2020.12.031
https://hdl.handle.net/10281/314811
https://doi.org/10.1016/j.jhep.2020.12.031
https://www.journal-of-hepatology.eu/article/S0168-8278(21)00024-6/fulltext
https://hdl.handle.net/11365/1286695
https://doi.org/10.1016/j.jhep.2020.12.031
https://curis.ku.dk/ws/files/333036705/mitochondrial_oxidative_metabolism_in_cca.pdf
https://hdl.handle.net/2158/1223058
https://doi.org/10.1016/j.jhep.2020.12.031

Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?: A Tool to Guide Post-Resection Adjuvant Chemotherapy?

Autori: Tsilimigras, Diamantis I Hyer, J Madison Paredes, Anghela Z a ďalší

Zdroj: Annals of Surgical Oncology. 28:1970-1978

Predmety: Prognosis, Bile Duct Neoplasms* / surgery, HCC CHBPT, Tumor Burden, 3. Good health, Cholangiocarcinoma, 03 medical and health sciences, Cholangiocarcinoma* / surgery, 0302 clinical medicine, Bile Duct Neoplasms, Chemotherapy, Adjuvant, Cholangiocarcinoma* / drug therapy, Hepatectomy, Humans, Bile Duct Neoplasms* / drug therapy

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/33259043
https://pubmed.ncbi.nlm.nih.gov/33259043/
https://link.springer.com/content/pdf/10.1245/s10434-020-09393-7.pdf
https://www.ncbi.nlm.nih.gov/pubmed/33259043
https://repub.eur.nl/pub/132192
https://hdl.handle.net/11562/1079656
https://doi.org/10.1245/s10434-020-09393-7
http://hdl.handle.net/10400.17/4263

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma

Autori: Leon Schönfeld Jan B. Hinrichs Steffen Marquardt a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: Male, Salvage Therapy, Uveal Neoplasms, Aged [MeSH], Original Article – Clinical Oncology, Progression-Free Survival [MeSH], Cholangiocarcinoma/drug therapy [MeSH], Melphalan/administration, Uveal Neoplasms/secondary [MeSH], Male [MeSH], Chemotherapy, Cancer, Regional Perfusion/methods [MeSH], Antineoplastic Agents, Alkylating/administration, Bile Duct Neoplasms/drug therapy [MeSH], Cholangiocarcinoma, Melanoma/drug therapy [MeSH], Salvage Therapy/instrumentation [MeSH], Female [MeSH], Percutaneous hepatic perfusion, Humans [MeSH], Melanoma/secondary [MeSH], Uveal Neoplasms/drug therapy [MeSH], Retrospective Studies [MeSH], Bile Duct Neoplasms/pathology [MeSH], Middle Aged [MeSH], Cholangiocarcinoma/pathology [MeSH], Ocular melanoma, Chemotherapy, Cancer, Regional Perfusion/instrumentation [MeSH], Salvage Therapy/methods [MeSH], Liver Neoplasms/drug therapy [MeSH], Liver Neoplasms, Middle Aged, Progression-Free Survival, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Bile Duct Neoplasms, Uveal Melanoma, Chemotherapy, Cancer, Regional Perfusion, Humans, Female, Antineoplastic Agents, Alkylating, Melanoma, Melphalan, Aged, Retrospective Studies

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-020-03289-5.pdf
https://pubmed.ncbi.nlm.nih.gov/32564137
https://www.ncbi.nlm.nih.gov/pubmed/32564137
https://pubmed.ncbi.nlm.nih.gov/32564137/
https://link.springer.com/content/pdf/10.1007/s00432-020-03289-5.pdf
https://link.springer.com/article/10.1007/s00432-020-03289-5
https://www.scilit.net/article/626821540d11270c8bb536abb51592ef
https://repository.publisso.de/resource/frl:6469348

Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging

Autori: Felix Hahn Lukas Müller Florian Jungmann a ďalší

Prispievatelia: Felix Hahn Lukas Müller Florian Jungmann a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: Male, ddc:610, CA-19-9 Antigen, Original Article – Clinical Oncology, Cholangiocarcinoma/diagnosis [MeSH], Bile Duct Neoplasms/mortality [MeSH], Aged [MeSH], Cholangiocarcinoma/drug therapy [MeSH], Neoplasm Staging [MeSH], Male [MeSH], Survival prediction, Bile Duct Neoplasms/drug therapy [MeSH], Biomarkers, Tumor [MeSH], CA-19-9 Antigen [MeSH], Female [MeSH], Kaplan-Meier Estimate [MeSH], Humans [MeSH], Bile Duct Neoplasms/diagnosis [MeSH], RECIST 1.1, Retrospective Studies [MeSH], Middle Aged [MeSH], Intrahepatic cholangiocarcinoma, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Cholangiocarcinoma/mortality [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], ROC Curve [MeSH], Prognosis [MeSH], Chemotherapy, 610 Medizin, Kaplan-Meier Estimate, Middle Aged, Prognosis, 3. Good health, Cholangiocarcinoma, 03 medical and health sciences, 0302 clinical medicine, Bile Duct Neoplasms, ROC Curve, 610 Medical sciences, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Female, 10. No inequality, Aged, Neoplasm Staging, Retrospective Studies

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-020-03200-2.pdf
https://pubmed.ncbi.nlm.nih.gov/32232655
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256028
https://link.springer.com/article/10.1007/s00432-020-03200-2
https://link.springer.com/content/pdf/10.1007/s00432-020-03200-2.pdf
https://www.ncbi.nlm.nih.gov/pubmed/32232655
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256028
https://pubmed.ncbi.nlm.nih.gov/32232655/
https://openscience.ub.uni-mainz.de/handle/20.500.12030/5756
https://doi.org/10.25358/openscience-5747
https://repository.publisso.de/resource/frl:6467694

FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma.

Autori: Cleary, J.M. Raghavan, S. Wu, Q. a ďalší

Predmety: Adolescent, Adult, Aged, 80 and over, Bile Duct Neoplasms/drug therapy, Bile Duct Neoplasms/genetics, Bile Duct Neoplasms/pathology, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/genetics, Cholangiocarcinoma/pathology, Female, Humans, Male, Middle Aged, Molecular Targeted Therapy, Protein Kinase Inhibitors/therapeutic use, Receptor, Fibroblast Growth Factor, Type 2/antagonists & inhibitors, Type 2/genetics, Young Adult

Relation: Cancer Discovery; https://iris.unil.ch/handle/iris/176134; serval:BIB_794632510938; 000704194700027

Dostupnosť: https://iris.unil.ch/handle/iris/176134
https://doi.org/10.1158/2159-8290.CD-20-1669

Photodynamic therapy of nonresectable cholangiocarcinoma

Autori: Ortner, M. A. Liebetruth, J. Schreiber, S. a ďalší

Predmety: Bile Duct Neoplasms/*drug therapy *Bile Ducts, Intrahepatic Bilirubin/blood Cholangiocarcinoma/*drug therapy/psychology Humans Length of Stay *Photochemotherapy/adverse effects Quality of Life Stents Survival Rate

Relation: Gastroenterology; https://iris.unil.ch/handle/iris/175183; serval:BIB_6F08010AB4EB; 000072250000019; 9496944

Dostupnosť: https://iris.unil.ch/handle/iris/175183
https://doi.org/10.1016/S0016-5085(98)70537-2

Photodynamic therapy for cholangiocarcinoma.

Autori: Ortner, M.

Predmety: Adult, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Bile Duct Neoplasms/drug therapy, Bile Duct Neoplasms/surgery, Bile Ducts, Intrahepatic, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/surgery, Dihematoporphyrin Ether/therapeutic use, Drainage, Female, Humans, Male, Middle Aged, Palliative Care, Photochemotherapy

Relation: Journal of hepato-biliary-pancreatic surgery; https://iris.unil.ch/handle/iris/142391; serval:BIB_D0CACDBCAD08

Dostupnosť: https://iris.unil.ch/handle/iris/142391
https://doi.org/10.1007/s005340170036

Identification of a Pan‐Gamma‐Secretase Inhibitor Response Signature for Notch‐Driven Cholangiocarcinoma

Autori: Colm J. O’Rourke Matthias S. Matter Chirag Nepal a ďalší

Zdroj: Hepatology. 71:196-213

Predmety: 0301 basic medicine, Fluorenes, 0303 health sciences, Tumor, Receptors, Notch, Bile Duct Neoplasms/drug therapy, Benzazepines, Ketones, Dibenzazepines/pharmacology, Cell Line, 3. Good health, Cholangiocarcinoma, 03 medical and health sciences, Treatment Outcome, Bile Duct Neoplasms, Dibenzazepines, Cell Line, Tumor, Receptors, Cholangiocarcinoma/drug therapy, Humans, Notch/drug effects, Amyloid Precursor Protein Secretases/antagonists & inhibitors, Amyloid Precursor Protein Secretases

Prístupová URL adresa: https://europepmc.org/articles/pmc6918012?pdf=render
https://pubmed.ncbi.nlm.nih.gov/31211856
https://europepmc.org/article/MED/31211856
https://pubmed.ncbi.nlm.nih.gov/31211856/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918012
https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.30816
https://onlinelibrary.wiley.com/doi/abs/10.1002/hep.30816

Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma

Prispievatelia: Kyungjoo Cho Hyuk Moon Sang Hyun Seo a ďalší

Predmety: Anilides / administration & dosage, Anilides / pharmacology, Animals, Bile Duct Neoplasms / drug therapy, Bile Duct Neoplasms / genetics, Bile Duct Neoplasms / metabolism, Bile Duct Neoplasms / pathology, Cell Line, Tumor, Cell Proliferation / drug effects, Cell Survival / drug effects, Cholangiocarcinoma / drug therapy, Cholangiocarcinoma / genetics, Cholangiocarcinoma / metabolism, Cholangiocarcinoma / pathology, Down-Regulation, Gene Expression Regulation, Neoplastic / drug effects, Hedgehog Proteins / metabolism, Humans, Male, Mice, Nuclear Proteins / genetics, Pyridines / administration & dosage, Pyridines / pharmacology, Signal Transduction / drug effects, Xenograft Model Antitumor Assays, Zinc Finger Protein GLI1 / genetics, Zinc Finger Protein Gli2 / genetics, cholangiocarcinoma

Popis súboru: application/pdf

Relation: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; J01133; https://ir.ymlib.yonsei.ac.kr/handle/22282913/187446; T202105715

Dostupnosť: https://ir.ymlib.yonsei.ac.kr/handle/22282913/187446
https://doi.org/10.3390/ijms222413214

A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer

Autori: Seung Woo Park Seung Woo Yi Hee Man Kim a ďalší

Prispievatelia: Seung Woo Park Seung Woo Yi Hee Man Kim a ďalší

Zdroj: Cancer Chemotherapy and Pharmacology. 78:841-846

Predmety: Male, Survival, Antimetabolites, Chemoradiotherapy/methods, Common Bile Duct Neoplasms/drug therapy, Biliary Tract Neoplasms/radiotherapy, Pilot Projects, Chemoradiotherapy/adverse effects, Deoxycytidine, Cholangiocarcinoma, Deoxycytidine/analogs & derivatives, 0302 clinical medicine, Antineoplastic/administration & dosage, Antineoplastic Combined Chemotherapy Protocols, Tomography, Chemoradiotherapy, Middle Aged, Biliary Tract Neoplasms/drug therapy, Klatskin Tumor/radiotherapy, Combined Modality Therapy, Antineoplastic Agents/administration & dosage, X-Ray Computed, 3. Good health, Common Bile Duct Neoplasms/radiotherapy, Gallbladder Neoplasms/drug therapy, Treatment Outcome, Biliary Tract Neoplasms, Biliary Tract Neoplasms/diagnostic imaging, Female, Gallbladder Neoplasms, Adult, Antimetabolites, Antineoplastic, Common Bile Duct Neoplasms, Antineoplastic Agents, Disease-Free Survival, 03 medical and health sciences, Gallbladder Neoplasms/radiotherapy, Cholangiocarcinoma/drug therapy, Humans, Deoxycytidine/administration & dosage, Aged, Klatskin Tumor/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Gemcitabine, Cholangiocarcinoma/radiotherapy, Biliary tract cancer, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cisplatin, Cisplatin/administration & dosage, Klatskin Tumor

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/27586966

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer

Autori: Hye Lim Jang Ho Yeong Lim Young Suk Park a ďalší

Prispievatelia: Hye Lim Jang Ho Yeong Lim Young Suk Park a ďalší

Zdroj: Transl Oncol
Translational Oncology, Vol 8, Iss 1, Pp 40-46 (2015)
TRANSLATIONAL ONCOLOGY(8): 1

Predmety: Male, 0301 basic medicine, Deoxycytidine/analogs & derivatives, Cancer Research, Gallbladder Neoplasms/drug therapy, Biliary Tract Neoplasms/epidemiology, Cholangiocarcinoma/pathology, Quinazolines/adverse effects, Biliary Tract Neoplasms/pathology, Disease-Free Survival, Article, Erlotinib Hydrochloride, Quinazolines/therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Gallbladder Neoplasms/pathology, Humans, Organoplatinum Compounds/adverse effects, Neoplasm Metastasis, Organoplatinum Compounds/administration & dosage, Deoxycytidine/administration & dosage, RC254-282, Aged, Neoplasm Staging, Deoxycytidine/adverse effects, Gallbladder Neoplasms/epidemiology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cholangiocarcinoma/epidemiology, Middle Aged, Biliary Tract Neoplasms/drug therapy, Organoplatinum Compounds/therapeutic use, Quinazolines/administration & dosage, 3. Good health, Oncology, Cholangiocarcinoma/drug therapy, Disease Progression, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, Deoxycytidine/therapeutic use

Popis súboru: 40~46

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/25749176
https://doaj.org/article/6e68cdfd223a4dd3b92bede36ed829c6
http://open-repository.kisti.re.kr/cube/handle/open_repository/481967.do
https://mdanderson.elsevierpure.com/en/publications/molecular-subgroup-analysis-of-clinical-outcomes-in-a-phase-3-stu
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141497
https://www.sciencedirect.com/science/article/pii/S1936523314001375
https://mdanderson.influuent.utsystem.edu/en/publications/molecular-subgroup-analysis-of-clinical-outcomes-in-a-phase-3-stu
http://europepmc.org/articles/PMC4350637
https://pubmed.ncbi.nlm.nih.gov/25749176/

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology

Autori: Borbath, Ivan Ceratti, Antonino Verslype, Chris a ďalší

Prispievatelia: Borbath, Ivan Ceratti, Antonino Verslype, Chris a ďalší

Zdroj: Annals of Oncology, Vol. 24, no.11, p. 2824-2829 (2013)

Predmety: Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects, Proto-Oncogene Proteins -- genetics, Adult, Male, 0301 basic medicine, Cetuximab, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, Deoxycytidine, Antibodies, Disease-Free Survival, Cholangiocarcinoma, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, 0302 clinical medicine, ras Proteins -- genetics, Proto-Oncogene Proteins, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, KRAS, Chemotherapy, Humans, Aged, Aged, 80 and over, Middle Aged, Gemcitabine, Humanized -- administration & dosage -- adverse effects, 3. Good health, Cancérologie, Bile Duct Neoplasms, Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives, ras Proteins, Cholangiocarcinoma -- drug therapy -- genetics -- pathology, Female, Bile Duct Neoplasms -- drug therapy -- genetics -- pathology, Hématologie

Popis súboru: 1 full-text file(s): application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/23975665
https://biblio.ugent.be/publication/4213491
https://www.sciencedirect.com/science/article/pii/S0923753419373569
https://academic.oup.com/annonc/article/24/11/2824/201870
https://core.ac.uk/display/34098413
https://europepmc.org/abstract/MED/23975665
https://dial.uclouvain.be/pr/boreal/object/boreal:156079
https://hdl.handle.net/2078.1/156079

Study protocol of an open-label, single-arm, phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC)

Autori: Linde Kehmann Marie-Luise Berres Maria Gonzalez-Carmona a ďalší

Zdroj: BMC Cancer
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
BMC cancer 23, 470 (2023). doi:10.1186/s12885-023-10972-6

Predmety: Adult, Disease Progression [MeSH], Trifluridine/adverse effects [MeSH], Cholangiocarcinoma/drug therapy [MeSH], Translational research, Cholangiocarcinoma/etiology [MeSH], Biliary tract cancer, Gall bladder carcinoma, Biliary Tract Neoplasms/drug therapy [MeSH], Bile Duct Neoplasms/drug therapy [MeSH], FTD/TPI (Trifluridine/Tipiracil), Cholangiocarcinoma, Clinical Trials, Phase II as Topic [MeSH], Frontotemporal Dementia/drug therapy [MeSH], Adult [MeSH], Study Protocol, Humans [MeSH], Prospective Studies [MeSH], Multicenter Studies as Topic [MeSH], Cisplatin [MeSH], Gemcitabine [MeSH], Bile Duct Neoplasms/etiology [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Medical and Health Sciences, Irinotecan [MeSH], Second-line treatment, Bile Ducts, Intrahepatic/pathology [MeSH], Deoxycytidine [MeSH], Colorectal Neoplasms/pathology [MeSH], Chemotherapy, Frontotemporal Dementia/chemically induced [MeSH], Irinotecan, Deoxycytidine, Trifluridine, 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Multicenter Studies as Topic, Prospective Studies, RC254-282, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Gemcitabine, 3. Good health, Bile Ducts, Intrahepatic, Biliary Tract Neoplasms, Bile Duct Neoplasms, Frontotemporal Dementia, Disease Progression, Cisplatin, Colorectal Neoplasms

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37217885
https://doaj.org/article/adcfd14080b94e43bba7e5c89b37d3ba
https://repository.publisso.de/resource/frl:6485085
https://publications.rwth-aachen.de/record/982741

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14)

Prispievatelia: Choong-Kun Lee Hong Jae Chon Jaekyung Cheon a ďalší

Predmety: Antineoplastic Combined Chemotherapy Protocols / adverse effects, Bile Duct Neoplasms* / drug therapy, Bile Ducts, Intrahepatic / pathology, Biliary Tract Neoplasms* / pathology, Cholangiocarcinoma* / drug therapy, Cisplatin / adverse effects, Fluorouracil / adverse effects, Gemcitabine, Humans, Leucovorin / adverse effects, Oxaliplatin / therapeutic use, Quality of Life, Trastuzumab / adverse effects, psy, socio

Relation: https://ir.ymlib.yonsei.ac.kr/handle/22282913/195311

Dostupnosť: https://ir.ymlib.yonsei.ac.kr/handle/22282913/195311

Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I–II study

Autori: Laurent, Sébastien Monsaert, Els Boterberg, Tom a ďalší

Prispievatelia: Laurent, Sébastien Monsaert, Els Boterberg, Tom a ďalší

Zdroj: Annals of Oncology, Vol. 20, no. 8, p. 1369-1374 (2009)

Predmety: Adult, Male, Adenocarcinoma -- drug therapy -- radiotherapy, Organoplatinum Compounds, pancreatic cancer, Adenocarcinoma, chemotherapy, Deoxycytidine, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, Dose-Response Relationship, Cholangiocarcinoma, 03 medical and health sciences, 0302 clinical medicine, Pancreatic Neoplasms -- drug therapy -- radiotherapy -- surgery, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Humans, Prospective Studies, Cholangiocarcinoma -- drug therapy -- radiotherapy -- surgery, radiotherapy, Aged, Radiotherapy, Dose-Response Relationship, Drug, Cholangio carcinoma, oxaliplatin, gemcitabine, Pancreatic cancer, Sciences bio-médicales et agricoles, Middle Aged, Combined Modality Therapy, Gemcitabine, Organoplatinum Compounds -- administration & dosage -- adverse effects, 3. Good health, Oxaliplatin, Pancreatic Neoplasms, Treatment Outcome, Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives, Feasibility Studies, Female, Drug, cholangiocarcinoma

Popis súboru: 1 full-text file(s): application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/19457936
https://biblio.ugent.be/publication/824749
https://paperity.org/p/40569640/feasibility-of-radiotherapy-with-concomitant-gemcitabine-and-oxaliplatin-in-locally
https://core.ac.uk/display/55795822
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111388/Details
http://annonc.oxfordjournals.org/lookup/resid/mdp005?view=full&uritype=cgi
http://europepmc.org/abstract/MED/19457936
https://hdl.handle.net/2078.1/35409